Columbia Labs (CBRX) Raises Proceeds of $750K Through Sale of Stock to Numoda
Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that it has raised $750,000 through the sale of 451,807 shares of its common stock at a price of $1.66 per share to Numoda Corporation, which provides improved trial-performance metrics solutions in enrollment, logistics, monitoring and financial efficiencies for life sciences companies. Numoda is currently managing Columbia's ongoing PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study of PROCHIEVE(R) 8% (progesterone gel) to reduce the risk of preterm birth in women with a short cervix at mid-pregnancy.
Columbia Laboratories, Inc. engages in the research, development, manufacture, and commercialization of women's healthcare and endocrinology products.
Create E-mail AlertRelated Categories
Corporate NewsEquity Offerings
Stocks Mentioned
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
